Connect with us

Hi, what are you looking for?

Investing

Minerva Neurosciences Shares Rise 25% FDA Files NDA for Roluperidone

By Chris Wack

Minerva Neurosciences, Inc. shares were up 25%, to $3.50, after the company said that the U.S. Food and Drug Administration filed its New Drug Application for roluperidone for the treatment of negative symptoms in patients with schizophrenia.

The company said the decision to file the NDA follows its request for formal dispute…

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

If, however, you’re using an alternative banking method, you can click on the ‘Go to Alternative banking’ link to be directed to the page...

News

With other methods of payment, the cost of the conversion is passed onto the player and any winnings generated from that method are converted...

News

There are bonus terms and conditions that players must fulfil and all money received is forfeited when they end their active gaming session. Once...

News

You can find some of the most popular games available at the casino, including online slots, table games and video poker, and much more....